🇺🇸 FDA
Patent

US 10980841

Methods and compositions for in vivo induction of pancreatic beta cell formation

granted A61KA61K31/7088A61K35/39

Quick answer

US patent 10980841 (Methods and compositions for in vivo induction of pancreatic beta cell formation) held by The Board of Regents of the University of Texas System expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7088, A61K35/39, A61K38/1709, A61K38/45